Viewing Study NCT00493818


Ignite Creation Date: 2025-12-25 @ 5:03 AM
Ignite Modification Date: 2026-03-03 @ 12:24 PM
Study NCT ID: NCT00493818
Status: TERMINATED
Last Update Posted: 2017-01-18
First Post: 2007-06-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Open-label Study to Investigate the Safety, Tolerability, PK, and Pharmacodynamics of the AKT Inhibitor GSK690693
Sponsor: GlaxoSmithKline
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None GSK690693, View
None Solid Tumors, View
None Lymphoma, View
None AKT View